{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:34Z","timestamp":1792788154828,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ygyno.2026.10.003","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:41:57Z","timestamp":1792716117000},"page":"135-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A cross-sectional survey exploring experiences in accessing hormone replacement therapy following risk-reducing surgery for individuals with hereditary ovarian cancer risk"],"prefix":"10.1016","volume":"214","author":[{"given":"Shelby","family":"Thornton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"O'Loughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Nuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy","family":"Borle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesa","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney B.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2026.10.003_bb0005","series-title":"NCCN Guidelines Index Table of Contents Discussion. Risk Assessment","author":"Daly","year":"2024"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0010","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","article-title":"Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO clinical practice guideline","volume":"34","author":"Sessa","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.psyneuen.2019.03.013","article-title":"Surgical menopause in association with cognitive function and risk of dementia: a systematic review and meta-analysis","volume":"106","author":"Georgakis","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.maturitas.2009.08.003","article-title":"Premature menopause or early menopause: long-term health consequences","volume":"65","author":"Shuster","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygyno.2024.10.031","article-title":"What happens after menopause? (WHAM): impact of risk-reducing salpingo-oophorectomy on depressive and anxiety symptoms at 24 months","volume":"192","author":"Hickey","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ygyno.2021.07.029","article-title":"What happens after menopause? (WHAM): a prospective controlled study of vasomotor symptoms and menopause-related quality of life 12\u202fmonths after premenopausal risk-reducing salpingo-oophorectomy","volume":"163","author":"Hickey","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejogrb.2021.08.001","article-title":"The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1\/2 mutation carriers and women with lynch syndrome: a systematic review and meta-analysis","volume":"265","author":"Kershaw","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0045","article-title":"Sexual function following risk-reducing salpingo-oophorectomy: a prospective cohort study","volume":"12","author":"von Kartaschew","year":"2024","journal-title":"Sex. Med."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0050","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ygyno.2021.02.001","article-title":"What happens after menopause? (WHAM): a prospective controlled study of depression and anxiety up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy","volume":"161","author":"Hickey","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0055","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/GME.0000000000002361","article-title":"Gray matter volume in women with the BRCA mutation with and without ovarian removal: evidence for increased risk of late-life Alzheimer's disease or dementia","volume":"31","author":"Witt","year":"2024","journal-title":"Menopause"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0060","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/GME.0000000000002201","article-title":"Barriers to hormone therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1\/2 mutation carriers","volume":"30","author":"DiSilvestro","year":"2023","journal-title":"Menopause"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/AOG.0000000000005236","article-title":"Changes in bone density in carriers of BRCA1 and BRCA2 pathogenic variants after salpingo-oophorectomy","volume":"142","author":"Chan","year":"2023","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygyno.2010.12.326","article-title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation","volume":"121","author":"Finch","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0075","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ygyno.2019.06.017","article-title":"Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for reproductive medicine evidence-based review","volume":"155","author":"Chen","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0080","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jogc.2018.05.046","article-title":"No. 366-Gynaecologic management of hereditary breast and ovarian cancer","volume":"40","author":"Jacobson","year":"2018","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030711","article-title":"Long-term non-cancer risks in people with BRCA mutations following risk-reducing bilateral salpingo-oophorectomy and the role of hormone replacement therapy: a review","volume":"15","author":"Nitschke","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/medicina55090602","article-title":"The controversial history of hormone replacement therapy","volume":"55","author":"Cagnacci","year":"2019","journal-title":"Medicina"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10549-021-06436-9","article-title":"Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis","volume":"191","author":"Poggio","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1470-2045(06)70869-5","article-title":"Survival patterns after oophorectomy in premenopausal women: a population-based cohort study","volume":"7","author":"Rocca","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0105","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/AOG.0000000000004723","article-title":"Menopausal hormone therapy formulation and breast cancer risk","volume":"139","author":"Abenhaim","year":"2022","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0110","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE study group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0115","article-title":"Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2","author":"Kotsopoulos","year":"2025","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0120","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/GME.0000000000001629","article-title":"Factors associated with use of hormone therapy after preventive oophorectomy in BRCA mutation carriers","volume":"27","author":"Mejia-Gomez","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2023.10.023","article-title":"Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications","volume":"179","author":"Sasse","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygyno.2023.03.017","article-title":"Patterns of care and outcomes of risk reducing surgery in women with pathogenic variants in non-BRCA and lynch syndrome ovarian cancer susceptibility genes","volume":"173","author":"Schwartz","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2022.09.027","article-title":"Hormone replacement in premenopausal women treated with bilateral oophorectomy for ovarian cancer \u2013 a nationwide population-based study","volume":"167","author":"Von Kartaschew","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0140","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/GME.0000000000001560","article-title":"Factors associated with counseling and postoperative hormone therapy use in surgically menopausal women","volume":"27","author":"Verrilli","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0145","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/13697137.2023.2173567","article-title":"BRCA carriers after risk-reducing bilateral salpingo-oophorectomy: menopausal hormone therapy knowledge gaps, and the impact of physicians' recommendations","volume":"26","author":"Armon","year":"2023","journal-title":"Climacteric"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13053-015-0031-4","article-title":"Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers","volume":"13","author":"Etchegary","year":"2015","journal-title":"Hered Cancer Clin. Pract."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0155","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/pon.1152","article-title":"Peer-support in coping with medical uncertainty: discussion of oophorectomy and hormone replacement therapy on a web-based message board","volume":"16","author":"Kenen","year":"2007","journal-title":"Psychooncology"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0160","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0170","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","article-title":"STROBE reporting guidelines for observational studies","volume":"156","author":"Ghaferi","year":"2021","journal-title":"JAMA Surg."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0175","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1186\/s12889-022-13122-y","article-title":"Racism in healthcare: a scoping review","volume":"22","author":"Hamed","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0180","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/jgc4.1644","article-title":"Considerations for the use of qualitative methodologies in genetic counseling research","volume":"32","author":"Wainstein","year":"2023","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0185","doi-asserted-by":"crossref","DOI":"10.1177\/2158244014522633","article-title":"Qualitative content analysis: a focus on trustworthiness","volume":"4","author":"Elo","year":"2014","journal-title":"SAGE Open"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0190","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.NNR.0000313482.33917.7d","article-title":"From text to codings: intercoder reliability assessment in qualitative content analysis","volume":"57","author":"Burla","year":"2008","journal-title":"Nurs. Res."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0240","series-title":"Health Equity for Persons with Disabilities: Guide for Action. Executive Summary","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0205","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ygyno.2026.05.018","article-title":"Uptake of risk-reducing medical interventions among female BRCA1\/2 pathogenic variant carriers: a population-based study in British Columbia","volume":"210","author":"Lloyd-Ellis","year":"2026","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0210","article-title":"Psychological impact of risk-reducing surgery for gynecologic cancer among women with Lynch syndrome","volume":"58","author":"Huband","year":"2025","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10689-017-9997-6","article-title":"Quality of life following prophylactic gynecological surgery: experiences of female Lynch mutation carriers","volume":"17","author":"Etchegary","year":"2018","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0220","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.2147\/PPA.S430203","article-title":"Barriers to accessing effective treatment and support for menopausal symptoms: a qualitative study capturing the behaviours, beliefs and experiences of key stakeholders","volume":"17","author":"Barber","year":"2023","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.ygyno.2026.10.003_bb0225","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.5001\/omj.2020.40","article-title":"Implications of language barriers for healthcare: a systematic review","volume":"35","author":"Al Shamsi","year":"2020","journal-title":"Oman Med. J."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0230","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10897-018-0254-4","article-title":"Involvement and influence of healthcare providers, family members, and other mutation carriers in the cancer risk management decision-making process of BRCA1 and BRCA2 mutation carriers","volume":"27","author":"Puski","year":"2018","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ygyno.2026.10.003_bb0235","series-title":"Social Determinants of Health and Health Inequalities","year":"2024"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826021542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826021542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:13:06Z","timestamp":1792786386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826021542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":46,"alternative-id":["S0090825826021542"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.10.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cross-sectional survey exploring experiences in accessing hormone replacement therapy following risk-reducing surgery for individuals with hereditary ovarian cancer risk","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}